The Pace of Prescribing: What Drives Clinicians to Adopt New Treatments

Physicians are evaluating new therapies – Sermo data reveals what guides their decisions

Sponsored by Sermo
7th April 2026

The healthcare landscape is always evolving, bringing clinicians a steady stream of newly approved therapies and indications. Each one presents the possibility of improved patient outcomes, but also prompts important questions: What does the evidence show? How does this compare to current options? And when is the right moment to begin prescribing? 

To understand how physicians navigate this evolving reality, Sermo surveyed 228 U.S. physicians across specialties* to assess how they evaluate new treatments, how quickly they integrate them into practice, and what information they rely on most. The findings illuminate a clinician community that is both deeply committed to innovation and exceptionally thoughtful in how they adopt it. 

This data offers a roadmap for life science leaders seeking to support physicians more effectively: what to communicate, when to communicate, and how to enable confident, informed decision-making at every stage of the launch journey. 

Clinicians Are Actively Engaging with New Treatment Options 

Across the care landscape, physicians are steadily incorporating emerging therapies into practice. Their approach is thoughtful and consistent, reflecting a commitment to staying current, evaluating new evidence, and ensuring patients have access to the most relevant treatment options available. 

In the last three months, 70% of clinicians have introduced a newly launched pharmaceutical brand into their practice, and 73% have prescribed a newly...

Most Popular Content